Highly potent intracellular membrane-associated Aβ seeds

Anne-Marie Marzesco1,2, Matthias Flötenmeyer3, Anika Bühler1,2

  • 1Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076 Tübingen, Germany.

Scientific Reports
|June 18, 2016
PubMed

Insights

Alzheimer's disease amyloid-beta seeds are found on membranes, not just fibrils. These membrane-bound seeds drive aggregation and disease progression, offering new therapeutic targets.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Alzheimer's disease (AD) pathogenesis involves amyloid-beta (Aβ) peptide aggregation.
  • Prion-like seeding is a proposed mechanism for Aβ aggregate formation.
  • The precise molecular nature and location of Aβ seeds remain unclear.

Purpose of the Study:

  • To investigate the presence and role of Aβ seeds in membrane fractions.
  • To determine if membrane-associated Aβ seeds can initiate and propagate aggregation.
  • To explore the implications of intracellular Aβ seeds in AD.

Main Methods:

  • Separation and immunoisolation of membrane fractions from amyloid-laden brain homogenates.
  • Assay of Aβ seeding activity in membrane fractions.
  • In vitro and in vivo studies to assess the aggregation-inducing capacity of membrane-associated seeds.

Main Results:

  • Significant Aβ seeding activity was detected in membrane fractions, independent of detectable amyloid fibrils.
  • Aβ seeds associated with mitochondrial or related membranes effectively induced Aβ aggregation in vitro.
  • These membrane-bound seeds were capable of initiating β-amyloidosis in vivo.

Conclusions:

  • Membrane-associated Aβ seeds are a key component in early Alzheimer's disease pathogenesis.
  • Intracellular membrane-bound Aβ seeds may facilitate the spread of aggregation and downstream pathologies.
  • Targeting these membrane-associated seeds could offer novel therapeutic strategies for Alzheimer's disease.